# Observational Study in CLL Patients Receiving BR

> **NCT02381899** · — · COMPLETED · sponsor: **Czech CLL Study Group** · enrollment: 83 (actual)

## Conditions studied

- Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** Bendamustine and Rituximab

## Key facts

- **NCT ID:** NCT02381899
- **Lead sponsor:** Czech CLL Study Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2016-12
- **Final completion:** 2018-12
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2019-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02381899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02381899, "Observational Study in CLL Patients Receiving BR". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02381899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*